NLRP3 and Hepatic fibrosis: Furthermore, the role of IL-18 in activating HSCs and fostering liver fibrosis has been demonstrated, as the antagonism of IL-18 reduces collagen deposition and enhances metalloproteinase activity in myeloid-specific NLRP3 gain-of-function mutant mice [106].